Cargando…

Prevalence of Rifampicin-Resistant Tuberculosis among Patients Previously Treated for Pulmonary Tuberculosis in North-Western, Nigeria

BACKGROUND: Drug-resistant tuberculosis (TB) is a significant public health problem. Greater than 90% of rifampicin (RIF)-resistant isolates were also isoniazid resistant, and hence, rifampicin resistance (RR) is frequently used as a surrogate for multidrug-resistant TB. SETTING: This study was cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fadeyi, Abayomi, Desalu, Olufemi O., Ugwuoke, Chidi, Opanwa, Oji A., Nwabuisi, Charles, Salami, Alakija K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555224/ https://www.ncbi.nlm.nih.gov/pubmed/31198269 http://dx.doi.org/10.4103/nmj.NMJ_41_17

Ejemplares similares

Awareness of the Warning Signs, Risk Factors, and Treatment for Tuberculosis among Urban Nigerians
por: Desalu, Olufemi O., et al.
Publicado: (2013)

Cryptococcal antigen among HIV1-infected individuals in north-central Nigeria
por: Ezenabike, Chimezie, et al.
Publicado: (2020)

Clinical and microbiological profile of adult inpatients with community acquired pneumonia in Ilorin, North Central, Nigeria
por: Ojuawo, Olutobi Babatope, et al.
Publicado: (2020)

PREVALENCE, IDENTIFICATION AND ANTIFUNGAL SUSCEPTIBILITY OF DERMATOPHYTES CAUSING TINEA CAPITIS IN A LOCALITY OF NORTH CENTRAL NIGERIA
por: Ayodele, Ekundayo Halimat, et al.
Publicado: (2020)

Etiology, clinical characteristics, and management of pleural effusion in Ilorin, Nigeria
por: Adeoye, Peter Oladapo, et al.
Publicado: (2017)

Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay
por: Aladesanmi, Adeniyi Olatunji, et al.
Publicado: (2021)

Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria
por: Ulasi, Amara, et al.
Publicado: (2022)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Pattern of respiratory diseases seen among adults in an emergency room in a resource-poor nation health facility
por: Desalu, Olufemi Olumuyiwa, et al.
Publicado: (2011)

Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria
por: Ukwamedua, Henry, et al.
Publicado: (2019)

Advanced sickle cell associated interstitial lung disease presenting with cor pulmonale in a Nigerian
por: Fawibe, Ademola Emmanuel, et al.
Publicado: (2012)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin‐Treated Pulmonary Tuberculosis
por: Svensson, RJ, et al.
Publicado: (2016)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Prevalence, intensity and complications of Microsporidium spores amongst HIV-positive hospital patients in Ilorin, Nigeria
por: Nyamngee, Amase, et al.
Publicado: (2013)

Retrospective Analysis of the Serovars and Antibiogram of Vibrio cholerae Isolates of the 2017 Ilorin Cholera Outbreak, Nigeria
por: Amadu, Dele Ohinoyi, et al.
Publicado: (2021)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis
por: Uchoa, Breno Kristoffer Beleza, et al.
Publicado: (2019)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Evaluation of Current Knowledge, Awareness and Practice of Spirometry among Hospital -based Nigerian Doctors
por: Desalu, Olufemi O, et al.
Publicado: (2009)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Oral rifampicin interferes with urine dipstick tests for patients with pulmonary tuberculosis
por: Wang, Fei, et al.
Publicado: (2023)

Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
por: Stemkens, Ralf, et al.
Publicado: (2023)

Burden of Pulmonary Rifampicin-Resistant Tuberculosis in Kajiado, Kenya: An Observational Study
por: Cattaneo, Paolo, et al.
Publicado: (2023)

Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria
por: Adejumo, Olusola Adedeji, et al.
Publicado: (2018)

Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
por: Ali, Mohamed Muhumed, et al.
Publicado: (2023)

INCIDENCE OF RIFAMPICIN-RESISTANCE PRESUMPTIVE M. TUBERCULOSIS CASES AMONG OUTPATIENTS IN KEBBI STATE, NIGERIA
por: Danlami, Mohammed Bashar, et al.
Publicado: (2020)

Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria
por: Ejeh, Francis Enenche, et al.
Publicado: (2021)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
por: Gebretsadik, Daniel, et al.
Publicado: (2020)

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis
por: Brindle, Richard, et al.
Publicado: (2001)

A community survey of the pattern and determinants of household sources of energy for cooking in rural and urban south western, Nigeria
por: Desalu, Olufemi Olumuyiwa, et al.
Publicado: (2012)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Rifampicin-induced nephrotoxicity in a tuberculosis patient
por: Beebe, Alexandria, et al.
Publicado: (2015)

Chylothorax in a child with rifampicin-resistant tuberculosis
por: McLaren, B, et al.
Publicado: (2019)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l56f1mr01gs6g4b25karq73r83